Article
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.
American journal of human genetics - 1 Sept 2007
Faivre L, Collod-Beroud G, Loeys B L, Child A, Binquet C, Gautier E, Callewaert B, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N, Dietz H C, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Muti C, Plauchu H, Robinson P N, Adès L C, Biggin A, Benetts B, Brett M, Holman K J, De Backer J, Coucke P, Francke U, De Paepe A, Jondeau G, Boileau C
Abstract excerpt
Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been associated with a wide range of overlapping phenotypes. Clinical care is complicated by variable age at onset and the wide range of severity of aortic features. The factors that modulate phenotypical severity, both among and within families, remain to be determined. The availability of international FBN1 mutation Universal Mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
